Avadel Pharmaceuticals PLC (FRA:AWK)
€ 11.6 0 (0%) Market Cap: 1.12 Bil Enterprise Value: 1.05 Bil PE Ratio: 0 PB Ratio: 20.33 GF Score: 39/100

Avadel Pharmaceuticals PLC Provides Corporate Update Transcript

Jun 30, 2022 / 12:00PM GMT
Release Date Price: €2.4 (+11.11%)
Operator

Greetings, and welcome to the Avadel Pharmaceuticals business update conference call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce Brandi Robinson. You may begin.

Brandi Robinson
Avadel Pharmaceuticals plc - SVP of Corporate Affairs

Good morning, and thank you for joining us on our conference call for Avadel's business update. As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements.

These risks include risks that products in the development stage may not achieve scientific objectives or milestones or meet stringent regulatory requirements, uncertainties regarding market entry and acceptance of products and the impact of competitive products and pricing. These

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot